Table 4.
Univariable and Multivariable Analysis of 90-day Outcomes and Overall Revisions Among Matched Cohort of + TKA + DS and +TKA−DS From 2010 to 2021 Q1, Odds Ratios Represent Odds of 90-day Outcomes and Any Revision Surgery Among Patients Who + TKA + DS Compared With +TKA−DS Patients
Outcome Variables | Univariable | Multivariable (+TKA + DS Compared With + TKA−DS) | |||
+TKA−DS | +TKA+DS | P | OR (95% CI) | P | |
90-day outcomes | 1495 | 150 | |||
Any adverse events | 258 (17.3%) | 50 (33.3%) | <0.0001 | 2.5 (1.7-3.7) | <0.0001 |
Severe events | 126 (8.4%) | 23 (15.3%) | 0.0078 | 2.0 (1.2-3.2) | 0.0053 |
Cardiac event | <11 | <11 | 0.2035 | 3.0 (0.7-10.1) | 0.0955 |
DVT | 54 (3.6%) | <11 | 0.9895 | 1.1 (0.4-2.5) | 0.8110 |
PE | 34 (2.3%) | <11 | 1.0000 | 0.9 (0.2-2.5) | 0.8321 |
Sepsis | 22 (1.5%) | 13 (8.7%) | <0.0001 | 7.1 (3.3-14.7) | <0.0001 |
SSI | 22 (1.5%) | <11 | 0.8774 | 1.3 (0.3-4.0) | 0.6355 |
Minor events | 182 (12.2%) | 45 (30.0%) | <0.0001 | 3.3 (2.2-4.9) | <0.0001 |
AKI | 51 (3.4%) | 15 (10.0%) | 0.0002 | 3.4 (1.8-6.4) | 0.0001 |
Pneumonia | 38 (2.5%) | 25 (16.7%) | <0.0001 | 8.3 (4.7-14.4) | <0.0001 |
Transfusion | 29 (1.9%) | <11 | 0.7643 | 1.4 (0.4-3.6) | 0.5457 |
UTI | 58 (3.9%) | 17 (11.3%) | <0.0001 | 3.3 (1.8-5.7) | <0.0001 |
Wound complication | 43 (2.9%) | <11 | 0.9501 | 1.2 (0.4-2.7) | 0.7610 |
2-year revisions | 59 (3.9%) | <11 | 0.8350 | 1.2 (0.5-2.5) | 0.6780 |
AKI = acute kidney injury, TKA = total knee arthroplasty, UTI = urinary tract infection
Using a Bonferroni correction, significance was set at P < 0.0036.
Bold represents statistically significant data.